Dermal Structure and Collagens
The dermis constitutes the principal structural component of human skin, providing mechanical strength, elasticity, and a scaffold for the vascular, neural, and appendageal structures that sustain epidermal viability. Unlike the epidermis, the dermis is largely acellular, consisting primarily of extracellular matrix (ECM) produced by fibroblasts. Understanding dermal architecture at the molecular level is essential for interpreting the pathophysiology of connective tissue disorders, wound healing, and cutaneous aging.
Anatomical Organization of the Dermis
Papillary Dermis
The papillary dermis is the superficial layer immediately beneath the basement membrane zone, extending into the epidermal rete ridges as dermal papillae. This layer comprises approximately 10% of the total dermal thickness.
Structural characteristics:
- Thin, loosely arranged collagen fibrils (primarily types I and III)
- Fine elastic fibers (oxytalan and elaunin fibers) extending perpendicular to the DEJ
- High vascularity: Capillary loops within dermal papillae deliver nutrients to the avascular epidermis
- Abundant ground substance: Glycosaminoglycans and proteoglycans
- Cellular elements: Fibroblasts, mast cells, dermal dendritic cells
Clinical correlate: The dermal papillae create the fingerprint patterns (dermatoglyphics) visible on the palmar and plantar surfaces. Lichen planus characteristically demonstrates saw-tooth (irregular) acanthosis with wedge-shaped hypergranulosis and a band-like lymphocytic infiltrate obscuring the DEJ within the papillary dermis.
Reticular Dermis
The reticular dermis constitutes approximately 90% of the total dermal thickness and extends from the papillary dermis to the subcutaneous fat.
Structural characteristics:
- Thick, densely packed collagen bundles arranged in a basket-weave pattern
- Mature elastic fibers oriented horizontally, interconnecting with vertical extensions
- Fewer cells relative to ECM volume
- Houses skin appendages: Hair follicles, sebaceous glands, eccrine/apocrine glands
- Contains larger blood vessels and nerves
Clinical correlate: Scarring primarily involves the reticular dermis. Keloids extend beyond the original wound margins with abundant, disorganized collagen bundles. Hypertrophic scars remain within wound boundaries but show similarly excessive collagen deposition.
Collagen: Dominant ECM Component
Collagen comprises approximately 70-80% of the dry weight of the dermis. The collagen superfamily includes 29 genetically distinct types in vertebrate tissues, many of which are present in human skin.
Classification of Dermal Collagens
| Class | Types | Supramolecular Assembly | Key Features |
|---|---|---|---|
| Fibrillar | I, III, V | Large cross-striated fibrils | 640 Å banding pattern, quarter-stagger array |
| Network-forming | IV, VIII | Interlacing network | Basement membranes |
| Microfibrillar | VI | Independent microfibrils | Anchoring function |
| Anchoring fibril | VII | U-shaped anchoring fibrils | Sublamina densa |
| Transmembrane | XIII, XVII | Type 2 orientation | Hemidesmosomes, focal adhesions |
| FACIT | IX, XII, XIV, XIX, XX, XXI | Fibril-associated | Molecular bridges |
Type I Collagen
Type I collagen is the most abundant collagen in human dermis, accounting for approximately 80% of total dermal collagen.
Clinical appearance: Type I collagen provides skin tensile strength, resistance to stretching, and structural integrity visible clinically as normal skin texture and elasticity.
Histological characteristics: On H&E staining, Type I collagen appears as thick, eosinophilic (pink) fibers arranged in wavy bundles in the reticular dermis. With trichrome stains, Type I collagen shows blue or green coloration and exhibits parallel fiber arrangement that straightens under tension.
Dermoscopic correlation: Dense Type I collagen creates the white background color in dermoscopy, providing structural support for other dermoscopic features. In conditions affecting collagen (aging, sclerosis), dermoscopy shows altered white patterns and loss of normal structural organization.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | [α1(I)]₂α2(I) — two α1 chains, one α2 chain |
| Genes | COL1A1 (17q21.33), COL1A2 (7q21.3) |
| Molecule length | ~300 nm |
| Molecular weight | ~285 kDa (procollagen ~450 kDa) |
| Triple helix | Glycine-X-Y repeating sequence; glycine in every third position |
| Hydroxyproline content | ~10% of amino acids (stabilizes triple helix) |
| Hydroxylysine content | ~1% (required for cross-links) |
Assembly into Fibrils
Type I collagen molecules align in a quarter-stagger array, with each molecule displaced by approximately 67 nm (one D-period) relative to its neighbor. This arrangement produces the characteristic 640 Å (64 nm) banding pattern visible by transmission electron microscopy.
The quarter-stagger array creates alternating "gap" and "overlap" zones:
- Gap zones: Spaces between the ends of adjacent molecules (~35 nm)
- Overlap zones: Regions where molecules overlap (~29 nm)
Clinical significance: In osteogenesis imperfecta, glycine substitutions in the triple-helical domain prevent proper helix formation. The position of the mutation along the helix correlates with severity—mutations closer to the C-terminus are more severe due to C-to-N propagation of helix formation.
Type I Collagen and Disease
| Disease | Gene | Mutation Type | Mechanism |
|---|---|---|---|
| Osteogenesis imperfecta type I | COL1A1 | Null allele | Haploinsufficiency — 50% normal collagen |
| Osteogenesis imperfecta types II-IV | COL1A1, COL1A2 | Glycine substitutions | Dominant-negative — abnormal molecules incorporated into fibrils |
| EDS arthrochalasia type (VIIA, VIIB) | COL1A1, COL1A2 | Exon 6 skipping | Loss of N-propeptide cleavage site |
Type III Collagen
Type III collagen comprises approximately 10% of adult dermal collagen but is the dominant collagen during embryonic development and early wound healing.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | [α1(III)]₃ — homotrimer |
| Gene | COL3A1 (2q32.2) |
| Distribution | Blood vessels, GI tract, uterus, skin |
| Type I:III ratio | ~8:1 in adult dermis |
Developmental Regulation
During embryonic development, type III collagen predominates. Postnatally, type I collagen synthesis accelerates, establishing the characteristic adult ratio. In wound healing, type III collagen is initially deposited in granulation tissue, then gradually replaced by type I collagen during scar maturation (remodeling phase, 6-12+ months).
Ehlers-Danlos Syndrome Vascular Type (Type IV)
The most dangerous EDS subtype — arterial, intestinal, and uterine rupture.
| Feature | Details |
|---|---|
| Gene | COL3A1 |
| Inheritance | Autosomal dominant |
| Mutation types | Glycine substitutions (most severe), splice-site, haploinsufficiency |
| Mechanism | Dominant-negative: mutant α1(III) chains incorporate into homotrimers → structural weakness |
| Median survival | ~50 years |
| Cause of death | Arterial rupture (especially medium-sized arteries), sigmoid perforation, uterine rupture in pregnancy |
| Skin findings | Thin, translucent skin; visible veins; minimal wrinkling; acrogeria (aged appearance of hands/feet) |
| Minor criteria | Easy bruising, spontaneous pneumothorax, early-onset varicose veins |
Pathognomonic clinical feature: Thin, translucent skin with visible subcutaneous vessels, particularly over the chest and abdomen.
Type V Collagen
Type V collagen represents less than 5% of total dermal collagen but plays a critical regulatory role in fibril diameter control.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | [α1(V)]₂α2(V) — major form; additional α3(V) and α4(V) chains exist |
| Genes | COL5A1 (9q34.3), COL5A2 (2q32.2) |
| Location | Surface of large collagen fibrils |
| Function | Regulates lateral growth of type I collagen fibrils |
Fibril Diameter Regulation
Type V collagen molecules are positioned on the surface of type I/III collagen fibrils. The retained N-propeptide of α1(V) chains projects outward and sterically hinders further lateral aggregation, thus limiting fibril diameter.
In the absence of type V collagen:
- Fibril diameters become variable and irregular
- Cross-sections show "flower-like" morphology (irregular contours)
- Connective tissue mechanical integrity is compromised
Ehlers-Danlos Syndrome Classic Type (Types I and II)
| Feature | Details |
|---|---|
| Genes | COL5A1 (most common), COL5A2, rarely COL1A1 |
| Inheritance | Autosomal dominant |
| Mechanism | Haploinsufficiency — 50% reduction in type V collagen production |
| Skin hyperextensibility | Skin extends beyond normal limits but recoils (unlike cutis laxa) |
| Joint hypermobility | Beighton score ≥5/9 |
| Tissue fragility | "Cigarette paper" (papyraceous) scarring, atrophic scars |
| Molluscoid pseudotumors | Fleshy lesions over pressure points |
| Subcutaneous spheroids | Calcified fat lobule herniation, palpable |
Skin biopsy findings: Electron microscopy demonstrates irregular collagen fibril diameters and "flower-like" cross-sections.
Type VI Collagen
Type VI collagen forms an independent microfibrillar network distinct from the large collagen fibrils.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | α1(VI)α2(VI)α3(VI) — heterotrimer with additional α4-α6 chains described |
| Genes | COL6A1 (21q22.3), COL6A2 (21q22.3), COL6A3 (2q37.3) |
| Structure | Short triple helix (~105 nm) flanked by large globular domains |
| Supramolecular assembly | Beaded microfibrils (~105 nm periodicity) |
Function
Type VI collagen microfibrils serve an anchoring function, stabilizing:
- Collagen fibril assembly
- Basement membrane attachment to underlying matrix
- Cell-matrix interactions via integrin α1β1 and α2β1 binding
Clinical Correlations
Mutations in COL6A1, COL6A2, and COL6A3 cause congenital muscular dystrophies with minimal cutaneous phenotype:
- Ullrich congenital muscular dystrophy (severe, AR)
- Bethlem myopathy (mild, AD)
The relatively mild skin manifestations in these disorders reflect the redundancy of dermal ECM components.
Collagen Biosynthesis
Collagen synthesis is a complex, multi-step process involving intracellular post-translational modifications and extracellular processing.
Biosynthetic Pathway
Loading diagram...
Key Enzymes in Collagen Biosynthesis
| Enzyme | Gene(s) | Cofactors | Function | Disease if Deficient |
|---|---|---|---|---|
| Prolyl 4-hydroxylase | P4HA1, P4HA2, P4HB | Fe²⁺, α-KG, O₂, ascorbate | 4-hydroxyproline formation → helix stability | Scurvy |
| Lysyl hydroxylase 1 | PLOD1 | Fe²⁺, α-KG, O₂, ascorbate | Hydroxylysine formation → cross-links | EDS kyphoscoliotic (VI) |
| Lysyl hydroxylase 2 | PLOD2 | Same | Telopeptide hydroxylation | Bruck syndrome |
| Lysyl hydroxylase 3 | PLOD3 | Same | Glucosyltransferase activity also | Connective tissue disorder |
| ADAMTS2 | ADAMTS2 | Zn²⁺ | N-propeptide cleavage (types I, II, III) | EDS dermatosparaxis (VIIC) |
| BMP-1/Tolloid | BMP1 | Zn²⁺ | C-propeptide cleavage | Not established |
Prolyl Hydroxylation and Scurvy
Prolyl 4-hydroxylase catalyzes the hydroxylation of proline residues in the Y position of the Gly-X-Y sequence:
Proline + O₂ + α-ketoglutarate → 4-Hydroxyproline + CO₂ + Succinate
Ascorbic acid (vitamin C) is required to maintain the iron cofactor in its reduced (Fe²⁺) state. In scurvy (ascorbate deficiency):
- Prolyl hydroxylation is impaired
- Underhydroxylated collagen has lower melting temperature (Tm)
- Triple helix is unstable at body temperature (37°C)
- Clinical manifestations: Poor wound healing, gingival bleeding, perifollicular hemorrhages, corkscrew hairs
Collagen Cross-Linking
The tensile strength of collagen fibrils depends on covalent intermolecular cross-links formed by lysyl oxidase.
Lysyl Oxidase Family
| Enzyme | Gene | Key Features |
|---|---|---|
| Lysyl oxidase (LOX) | LOX | Classic enzyme; requires copper cofactor |
| LOXL1 | LOXL1 | Exfoliation glaucoma susceptibility |
| LOXL2 | LOXL2 | Cancer biology, fibrosis |
| LOXL3 | LOXL3 | Craniofacial development |
| LOXL4 | LOXL4 | Cartilage |
Cross-Linking Mechanism
Loading diagram...
Cross-Link Types
| Cross-Link | Type | Location | Stability |
|---|---|---|---|
| Dehydro-lysinonorleucine | Divalent | Skin, tendon | Immature, reducible |
| Dehydro-hydroxylysinonorleucine | Divalent | Skin, tendon | Immature, reducible |
| Pyridinoline (hydroxylysyl-pyridinoline) | Trivalent | Bone, cartilage, dermis | Mature, non-reducible |
| Deoxypyridinoline (lysyl-pyridinoline) | Trivalent | Bone, dentin | Mature, non-reducible |
Copper Deficiency and Cross-Linking
Lysyl oxidase requires copper as a cofactor. Copper deficiency impairs cross-linking:
| Condition | Gene | Mechanism | Clinical Features |
|---|---|---|---|
| Menkes syndrome | ATP7A | Defective copper absorption → systemic copper deficiency | Kinky hair, neurodegeneration, connective tissue laxity |
| Occipital horn syndrome | ATP7A | Allelic, milder | Occipital exostoses, bladder diverticula, skin laxity |
| Nutritional copper deficiency | — | Dietary | Rare; impaired wound healing |
| D-penicillamine toxicity | — | Copper chelation | Drug-induced cutis laxa |
Collagen Degradation: Matrix Metalloproteinases
The matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade ECM components.
MMP Classification
| Class | MMPs | Primary Substrates |
|---|---|---|
| Collagenases | MMP1, MMP8, MMP13 | Fibrillar collagens I, II, III |
| Gelatinases | MMP2, MMP9 | Gelatin, collagen IV, V, VII |
| Stromelysins | MMP3, MMP10, MMP11 | Proteoglycans, laminin, collagen IV |
| Matrilysins | MMP7, MMP26 | ECM components, pro-MMPs |
| Membrane-type | MMP14-17, MMP24 | Pro-MMP2, pericellular collagenolysis |
MMP1 (Interstitial Collagenase)
MMP1 is the prototypic interstitial collagenase, synthesized by fibroblasts and keratinocytes.
Cleavage specificity:
- α1(I) chain: Cleaves at Gly⁷⁷⁵-Ile⁷⁷⁶
- α2(I) chain: Cleaves at Gly⁷⁷⁵-Leu⁷⁷⁶
This single cleavage produces ¾ and ¼ fragments. These fragments have a lower Tm and spontaneously denature at 37°C, becoming susceptible to non-specific proteases (gelatinases).
MMP Regulation
| Level | Mechanism |
|---|---|
| Transcriptional | Cytokines (IL-1, TNF-α), growth factors, AP-1, NF-κB |
| Pro-enzyme activation | Proteolytic cleavage of N-terminal propeptide |
| Inhibition | TIMPs 1-4 (stoichiometric, 1:1 binding) |
| Pharmacological inhibition | Tetracyclines (chelate Ca²⁺/Zn²⁺), synthetic inhibitors |
TIMPs (Tissue Inhibitors of Metalloproteinases)
| TIMP | Primary MMP Targets | Key Features |
|---|---|---|
| TIMP-1 | MMP1, MMP3, MMP9 | Broadly inhibitory |
| TIMP-2 | MMP2, MT-MMPs | Also required for pro-MMP2 activation |
| TIMP-3 | MMPs, ADAMs, ADAMTSs | Bound to ECM |
| TIMP-4 | MMP2, MT1-MMP | Heart, brain |
MMPs in Dermatology
| Condition | MMP Involvement |
|---|---|
| Photoaging | MMP1, MMP3, MMP9 upregulated by UV → collagen degradation |
| Wound healing | MMPs essential for keratinocyte migration, ECM remodeling |
| Bullous diseases | MMP9 in BP blister fluid; gelatinases in tissue separation |
| Tumor invasion | MMP2, MMP9 facilitate basement membrane degradation |
| Recessive dystrophic EB | Loss of collagen VII → MMP-mediated dermal fibrosis, SCC development |
Ehlers-Danlos Syndromes: Master Table
| Type | Former Classification | Gene(s) | Protein | Inheritance | Key Features |
|---|---|---|---|---|---|
| Classic | I, II | COL5A1, COL5A2, COL1A1 | Type V collagen (or I) | AD | Skin hyperextensibility, joint hypermobility, atrophic scars |
| Classic-like | — | TNXB | Tenascin-X | AR | Similar to classic, possibly severe |
| Vascular | IV | COL3A1 | Type III collagen | AD | Arterial/organ rupture, thin translucent skin |
| Kyphoscoliotic | VI | PLOD1, FKBP14 | Lysyl hydroxylase 1 | AR | Severe muscle hypotonia, scoliosis, ocular fragility |
| Arthrochalasia | VIIA, VIIB | COL1A1, COL1A2 | Type I collagen (exon 6) | AD | Congenital hip dislocation, severe hypermobility |
| Dermatosparaxis | VIIC | ADAMTS2 | ADAMTS2 | AR | Severe skin fragility, sagging redundant skin |
| Hypermobile | III | Unknown (most) | Unknown | AD | Primarily joint hypermobility, chronic pain |
| Spondylodysplastic | — | B4GALT7, B3GALT6, SLC39A13 | GAG synthesis | AR | Short stature, skeletal dysplasia |
| Musculocontractural | — | CHST14, DSE | Dermatan sulfate synthesis | AR | Congenital contractures, characteristic facies |
| Myopathic | — | COL12A1 | Type XII collagen | AD/AR | Muscle hypotonia, proximal weakness |
| Periodontal | VIII | C1R, C1S | Complement C1r/C1s | AD | Severe periodontitis, pretibial plaques |
Summary
The dermis provides mechanical strength through a precisely organized collagen-based extracellular matrix. Type I collagen dominates (80%), with critical contributions from types III, V, and VI. Collagen biosynthesis requires ascorbate-dependent hydroxylation, and mature fibril strength depends on lysyl oxidase-mediated cross-linking. Degradation is controlled by the MMP/TIMP balance. Genetic defects in collagen genes or processing enzymes cause the Ehlers-Danlos syndromes, each with characteristic molecular mechanisms correlating with clinical phenotype.
This section establishes the molecular foundation for understanding dermal pathology, wound healing, and connective tissue disorders.
How to Cite
Cutisight. "Dermal Structure and Collagens." Encyclopedia of Dermatology [Internet]. 2026. Available from: https://cutisight.com/education/volume-02-normal-skin/part-01-embryology-anatomy-histology/07-hypodermis/01-dermal-structure-and-collagens
This is an open-access resource. Please cite appropriately when using in academic or clinical work.